Pediatr. pro Praxi, 2005; 3: 123-126

CONGENITAL HYPOTHYROIDISM

prof. MUDr. Olga Hníková CSc
Klinika dětí a dorostu, UK 3. LF a FNKV, Praha

Congenital hypothyroidism (CH) appears in two forms. Endemic CH with various degrees of irreversible impairments of brain development in newborns is a consequence of mother and child iodine deficiency (ID) during pregnancy. The elimination of ID in the whole world belongs to priority programs of WHO and UNICEF, as an unnecessary cause of mental retardation of whole populations. In the Czech Republic (CR) iodine sufficiency has been attained since the year 2000 in 6 to 65-year-old population. However, not until 2003 in neonates. Sporadic permanent CH is connected with developmental and situational impairments of the thyroid gland (TG) or thyroid hormonal (TH) synthesis. The causes of primary CH are multifactorial. In the past 15 years mutations of genes which are acting during development and hormonogenesis of TG are being gradually revealed in 1–5 % of CH. Neonatal laboratory screening from mid – eighties of last century was essential for early diagnosis and treatment of primary CH. In positive cases from screening are 60 % of CH with anatomical and localization impairments and 30–35 % of patients with dyshormonogenesis have the TG in normal position, often with neonatal goiter. Treatment with levo-thyroxine, initial dose 10–15 mcg/day should be introduced not later than on the 14th day after birth. The prognosis in early treated CH is excellent, with normal life expentances. Screening of CH using TSH screening method is also a useful tool for monitoring of iodine supply in newborns at a population level. In CH screening results occur also transient impairments. A complete TG examination, in hypothyroidism substitutional treatment and a careful following up of these children is esssential. Longitudinal following of results on mass screening of CH in CR (> 1 000 000 screened newborns) revealed the stable incidence of primary permanent CH 1:4 230 live born neonates, twice more frequent in girls. In 193 of molecular genetic examined CH patients from the screening had gene mutation only in 1 % of cases. Other inborn impairments were more frequent in CH patients in comparison with remaining population and included cardiac impairments – 10× more frequently, m. Down-3× more frequently and hearing impairments 20× more frequently. During the period of total thyroxine screening method (1985–1996) the incidence of congenital defects of thyroxine-binding-globulin in the Czech neonates was established as 1:2 900 live born neonates.

Keywords: Key words: congenital hypothyroidism endemic form, sporadic form, newborn mass screening, etiology, treatment, prognosis.

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hníková O. CONGENITAL HYPOTHYROIDISM. Pediatr. praxi. 2005;6(3):123-126.
Download citation

References

  1. Al Taji E, Biebermann H, Ambruger N, Haufs N, Limanova Z, Hnikova O, Lebl J, Grueters A, Krude H. Screening for mutations in congenital hypothyroidism in Czech population: low mutation rate and identification of a new PAX 8 mutation. Horm Res 2003; 60, (suppl 2): 17-18.
  2. Delange F, Dunn JT, Glinoer D (eds). Iodine deficiency in Europe: a continuig concern. New York, Plenum Press 1993: 1-491. Go to original source...
  3. Docker BM, Pfaffler R, Pohlenz J, Andler W.Congenital central hypothyroidism due to a homozygous mutation in the thyrotropin-beta subunit gene follows and autosomall recessive inheritance. J Clin Endocrinol Metab 1998; 83,5: 1762-1765. Go to original source...
  4. Dussault JH, Coulombe P, Laberge C, Letarte J, Guyda H, Khoury K. Preliminary report on a mass screening program for neonatal hypothyroidism. J Pediat 1975; 86: 670. Go to original source... Go to PubMed...
  5. ESPE Report. Revised guidelines for neonatal screening programmes for primary congenital hypothyroidism. Horm Res 1999; 52: 49-52. Go to original source...
  6. Glinoer D, Delange F. The potential repercussion of maternal, fetal and neonatal hypothyroxinemia on the progeny. Thyroid 2000: 871-887. Go to original source... Go to PubMed...
  7. Hníková O, Kračmar P. Kongenitální hypotyreoza. Hálkova sbírka pediatrických prací, Avicenum, 1989.
  8. Hníková O. Neonatální screening kongenitální hypotyreozy v ČR (výsledky a perspektivy). Čas Lék čes 2002; 141, 23: 747-748.
  9. Hníková O. Vrozené poruchy štítné žlázy. In: Lebl J, Zapletalová J, Koloušková S. Trendy soudobé pediatrie, ,Dětská endokrinologie" Galén 2004; sv.3: 278-288.
  10. Hnikova O, Delange F, Kracmar P, Vinohradska H, Bilek R. Experience in the monitoring of maternal and neonatal iodine supply in the Czech Republic. Ces-slov Pediat 2005; 60, 1: 3-6.
  11. Janssen O, Bertenshaw R,Takeda K, Weiss R, Refetoff S. Molecular basis of inherited thyroxine-binding globulin defects. Trends Endocrinol Metab 1992; 3: 49-53. Go to original source... Go to PubMed...
  12. Klein AH, Melzer S, Kenny FM. Improved prognosis in congenital hypothyroidism treated before age three month.J Pediat 1972; 81: 912-915. Go to original source... Go to PubMed...
  13. Krude H, Biebermann H, Schnabel D, Ambrugger P, Grueters A. Molecular pathogenesis of neonatal hypothyroidism. Horm Res 2000; Suppl 1: 2-18. Go to original source... Go to PubMed...
  14. Zamrazil V, Bílek R, Cerovska J, Delange F. The elimination of iodine deficiency in the Czech Republic: the steps towards success. Thyroid 2004; 14,1: 49-56. Go to original source... Go to PubMed...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.